EyeGate Pharmaceuticals I...

NASDAQ: EYEG · Real-Time Price · USD
35.63
-0.08 (-0.22%)
At close: Aug 18, 2025, 3:06 PM
35.65
0.05%
After-hours: Aug 18, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Revenue
16.02M
Cost of Revenue
n/a
Gross Profit
16.02M
Operating Income
2.64M
Interest Income
1.25M
Pretax Income
5.66M
Net Income
7.72M
Selling & General & Admin
5.54M
Research & Development
7.84M
Other Expenses
n/a
Operating Expenses
13.38M
Interest Expense
-21.45K
Selling & Marketing Expenses
n/a
Cost & Expenses
13.38M
Income Tax Expense
-2.07M
Shares Outstanding (Basic)
3.87M
Shares Outstanding (Diluted)
4.13M
EPS (Basic)
1.99
EPS (Diluted)
1.87
EBITDA
n/a
EBIT
5.64M
Depreciation & Amortization
n/a